| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Feb―10 |
Simulation of SARS-CoV-2 epidemic trends in Tokyo considering vaccinations, virus mutations, government policies and PCR tests |
Jianing Chu, Hikaru Morikawa, Yu Chen |
| 2 |
[GO] |
2023―Jan―21 |
Different clinical guidelines, common goal: To reduce COVID-19 mortality |
Liqin Sun, Jiaye Liu, Fang Zhao, Jun Chen, Hongzhou Lu |
| 3 |
[GO] |
2023―Jan―16 |
Pre-enriched saline gargle samples for detection of SARS-CoV-2 |
Peng Xu, Jing Chen, Chengchen Qian, Wenqiang Yu |
| 4 |
[GO] |
2023―Jan―15 |
For COVID-19, what are the priorities of normalized prevention and control strategies? |
Mingyu Luo, Fuzhe Gong, Jimin Sun, Zhenyu Gong |
| 5 |
[GO] |
2023―Jan―01 |
Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19 |
Bo Zhang, Fanghua Qi |
| 6 |
[GO] |
2022―Dec―25 |
Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are the subsequent impacts on and new challenges for healthcare systems? |
Kenji Karako, Peipei Song, Yu Chen, Takashi Karako |
| 7 |
[GO] |
2022―Dec―25 |
Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19? |
Jing Li, Yufen Yan, Fangzhou Dou, Jianjun Gao |
| 8 |
[GO] |
2022―Dec―08 |
Can nasal irrigation with chlorine dioxide be considered as a potential alternative therapy for respiratory infectious diseases? The example of COVID-19 |
Jing Cao, Yirong Shi, Min Wen, Yuanyuan Peng, Qiqi Miao, Xiaoning Liu, et al. (+3) Mingbin Zheng, Tetsuya Asakawa, Hongzhou Lu |
| 9 |
[GO] |
2022―Dec―08 |
Focusing on development of novel sampling approaches and alternative therapies for COVID-19: Are they still useful in an era after the pandemic? |
Tetsuya Asakawa |
| 10 |
[GO] |
2022―Dec―08 |
Verification of the efficiency of saline gargle sampling for detection of the Omicron variant of SARS-CoV-2, a pilot study |
Kun Qiao, Xiaoting Tao, Houming Liu, Mingbin Zheng, Tetsuya Asakawa, Hongzhou Lu |
| 11 |
[GO] |
2022―Sep―11 |
An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19 pandemic on the healthcare system in Japan? |
Kenji Karako, Peipei Song, Yu Chen, Takashi Karako |
| 12 |
[GO] |
2022―Jul―29 |
Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs) |
Tingting Fang, Xianyang Pan, Ju Huang, Jun Chen, Shuli Song, Qilin Zhan |
| 13 |
[GO] |
2022―Jul―16 |
The role of influenza in the era of COVID-19: Can we forget it? |
Ting Li, Tetsuya Asakawa, Hui Liu, Cordia Chu, Hongzhou Lu |
| 14 |
[GO] |
2022―Jun―21 |
How should designated COVID-19 hospitals in megacities implement a precise management strategy in response to Omicron? |
Jing Cao, Min Wen, Yirong Shi, Ting Huang, Yunlan Yi, Youfeng Su, et al. (+3) Xiaohui Liu, Yanling Chao, Hongzhou Lu |
| 15 |
[GO] |
2022―Jun―21 |
Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule |
Jing Zhang, Lili Liu, Guoliang Zhang, Mingqiang Li, Bitao Ma, Wenming Yang |
| 16 |
[GO] |
2022―Jun―16 |
Needs of cancer patients during the SARS-CoV-2 Omicron lockdown: A population-based survey in Shanghai, China |
Minxing Chen, Ruijia Li, Gang Ding, Chunlin Jin |
| 17 |
[GO] |
2022―Mar―16 |
An innovative two-wing model for balancing the demands of inpatients with COVID-19 and general medical service in a designated hospital for COVID-19 in Shenzhen, China |
Xiaoning Liu, Jing Cao, Yiling Ji, Ting Li, Zheng Zhu, Ting Huang, Hongzhou Lu |
| 18 |
[GO] |
2021―Dec―27 |
The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022 |
Peipei Song, Takashi Karako |
| 19 |
[GO] |
2021―Dec―17 |
From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases |
Mingyu Luo, Qinmei Liu, Jinna Wang, Zhenyu Gong |
| 20 |
[GO] |
2021―Aug―29 |
Considerations and guidance to control the rebound in COVID-19 cases |
Qian Li, Xiangming Zhan, Jun Wang, Hongzhou Lu |
| 21 |
[GO] |
2021―Aug―24 |
Update: Drug treatment options for coronavirus disease 2019 (COVID-19) |
Yueming Shao, Jun Chen, Hongzhou Lu |
| 22 |
[GO] |
2021―Jul―14 |
The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: Evaluation of an administrative claims database |
Kenichiro Sato, Tatsuo Mano, Yoshiki Niimi, Atsushi Iwata, Tatsushi Toda, Takeshi Iwatsubo |
| 23 |
[GO] |
2021―Jul―12 |
Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures |
Tatsuo Sawakami, Kenji Karako, Peipei Song, Wataru Sugiura, Norihiro Kokudo |
| 24 |
[GO] |
2021―Jun―30 |
Rapid evolution of the COVID-19 pandemic calls for a unified public health response |
Na He |
| 25 |
[GO] |
2021―Jun―25 |
Impact of China's COVID-19 prevention and control efforts on outbreaks of influenza |
Qian Li, Jun Wang, Haiwei Lv, Hongzhou Lu |
| 26 |
[GO] |
2021―Jun―15 |
Opportunities and challenges to the use of neutralizing monoclonal antibody therapies for COVID-19 |
Jie Su, Hongzhou Lu |
| 27 |
[GO] |
2021―Jun―15 |
What is always necessary throughout efforts to prevent and control COVID-19 and other infectious diseases? A physical containment strategy and public mobilization and management |
Mingyu Luo, Jimin Sun, Zhenyu Gong, Zhen Wang |
| 28 |
[GO] |
2021―Mar―25 |
Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease |
Ying Lv, Yuanyuan Ma, Yanhui Si, Xiaoyi Zhu, Lin Zhang, Haiyan Feng, et al. (+5) Di Tian, Yixin Liao, Tiefu Liu, Hongzhou Lu, Yun Ling |
| 29 |
[GO] |
2021―Mar―25 |
Burnout in nurses during the COVID-19 pandemic in China: New challenges for public health |
Lin Zhang, Ling Chai, Yihong Zhao, Lin Wang, Wenxiu Sun, Lingqing Lu, et al. (+2) Hongzhou Lu, Jianliang Zhang |
| 30 |
[GO] |
2021―Mar―18 |
COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer |
Yamin Chen, Luying Cheng, Rongna Lian, Ziwei Song, Jinhui Tian |
| 31 |
[GO] |
2021―Mar―18 |
New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals |
Jun Chen, Hongzhou Lu |
| 32 |
[GO] |
2021―Feb―22 |
Transitional care during COVID-19 pandemic in Japan: Calls for new strategies to integrate traditional approaches with information and communication technologies |
Yuka Sumikawa, Noriko Yamamoto-Mitani |
| 33 |
[GO] |
2021―Jan―28 |
Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021 |
Kenji Karako, Peipei Song, Yu Chen, Wei Tang, Norihiro Kokudo |
| 34 |
[GO] |
2020―Dec―26 |
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? |
Masashi Ohe, Ken Furuya, Houman Goudarzi |
| 35 |
[GO] |
2020―Dec―24 |
Latest updates on COVID-19 vaccines |
Qian Li, Hongzhou Lu |
| 36 |
[GO] |
2020―Dec―17 |
Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China |
Yi Su, Yun Ling, Yuyan Ma, Lili Tao, Qing Miao, Qingfeng Shi, et al. (+3) Jue Pan, Hongzhou Lu, Bijie Hu |
| 37 |
[GO] |
2020―Oct―24 |
An overview of potential therapeutic agents to treat COVID-19 |
Xueqin Dong, Zhenxue Tian, Chengwu Shen, Cuirong Zhao |
| 38 |
[GO] |
2020―Oct―24 |
The development of a quarantine strategy is an important path to a normalized response to COVID-19 |
Han Zhu, Hongzhou Lu |
| 39 |
[GO] |
2020―Jun―20 |
Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China |
Mingshan Xue, Peiyan Zheng, Xiqing Bian, Zhifeng Huang, Huimin Huang, Yifeng Zeng, et al. (+6) Haisheng Hu, Xiaoqing Liu, Luqian Zhou, Baoqing Sun, Jian-lin Wu, Nanshan Zhong |
| 40 |
[GO] |
2020―Jun―11 |
Potential for jaktinib hydrochloride to treat cytokine storms in patients with COVID-19 |
Xianmin Meng, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, Hongzhou Lu |
| 41 |
[GO] |
2020―May―27 |
Predicting intervention effect for COVID-19 in Japan: state space modeling approach |
Genya Kobayashi, Shonosuke Sugasawa, Hiromasa Tamae, Takayuki Ozu |
| 42 |
[GO] |
2020―May―15 |
Does immune privilege result in recovered patients testing positive for COVID-19 again? |
Jufeng Xia |
| 43 |
[GO] |
2020―May―08 |
Introduction on collective quarantine of close contacts of patients with COVID-19 for medical observation in China: from the perspective of frontline staff |
Chenjie Dong, Yuan Tian, Wenzhong Xu, Jiangjiang He, Duo Chen, Jie Zhu, Ping Lu |
| 44 |
[GO] |
2020―Apr―29 |
Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China |
Ying Zou, Hongying Guo, Yuyi Zhang, Zhengguo Zhang, Yu Liu, Jiefei Wang, et al. (+2) Hongzhou Lu, Zhiping Qian |
| 45 |
[GO] |
2020―Apr―26 |
Suggestions on surgical treatment during coronavirus disease 2019 (COVID-19) pandemic |
Zhiming Zhao, Mengyang Li, Rong Liu |
| 46 |
[GO] |
2020―Apr―21 |
Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up |
Jiao Zhang, Shoucai Wu, Lingzhong Xu |
| 47 |
[GO] |
2020―Apr―21 |
A practice of anesthesia scenario design for emergency cesarean section in patients with COVID-19 infection based on the role of standard patient |
Yin Kang, Longjiao Deng, Dengwen Zhang, Yuehong Wang, Gang Wang, Li Mei, et al. (+2) Guobin Zhou, Haihua Shu |
| 48 |
[GO] |
2020―Apr―12 |
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) |
Jianjun Gao, Shasha Hu |
| 49 |
[GO] |
2020―Apr―04 |
Macrolide treatment for COVID-19: Will this be the way forward? |
Masashi Ohe, Haruki Shida, Satoshi Jodo, Yoshihiro Kusunoki, Masahide Seki, Ken Furuya, Houman Goudarzi |
| 50 |
[GO] |
2020―Mar―31 |
Mobile field hospitals, an effective way of dealing with COVID-19 in China: sharing our experience |
Zhi Chen, Shan He, Fan Li, Junxiang Yin, Xiaoliang Chen |
| 51 |
[GO] |
2020―Mar―18 |
Analysis of COVID-19 infection spread in Japan based on stochastic transition model |
Kenji Karako, Peipei Song, Yu Chen, Wei Tang |
| 52 |
[GO] |
2020―Feb―24 |
COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern |
Peipei Song, Takashi Karako |
| 53 |
[GO] |
2020―Feb―18 |
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies |
Jianjun Gao, Zhenxue Tian, Xu Yang |
| 54 |
[GO] |
2020―Feb―16 |
Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China |
Xu Wang, Xiaoxi Zhang, Jiangjiang He |
| 55 |
[GO] |
2020―Feb―08 |
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment |
Zhenwei Wang, Xiaorong Chen, Yunfei Lu, Feifei Chen, Wei Zhang |
| 56 |
[GO] |
2020―Jan―27 |
Drug treatment options for the 2019-new coronavirus (2019-nCoV) |
Hongzhou Lu |
